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tissuelike differentiation marker com-
pounds, including villin, keratins, and
specific lung epithelium marker com-
pounds, and by the production of tissue
mucin.
In a series of initial infection tests, TLA
cultures were inoculated with human res-
piratory syncytial viruses and parain-
fluenza type 3 viruses. Infection was con-
firmed by photomicrographs that showed
signs of damage by viruses and virus titers
(see figure) that indicated large increases
in the populations of viruses during the
days following inoculation.
This work was done by Thomas J. Good-
win of Johnson Space Center. Further in-
formation is contained in a TSP (see
page 1). 
This invention is owned by NASA, and a
patent application has been filed. Inquiries con-
cerning nonexclusive or exclusive license for its
commercial development should be addressed to
the Patent Counsel, Johnson Space Center,
(281) 483-0837. Refer to MSC-24164-1.
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Strategies were explored for inactivat-
ing resistance-bearing microorganisms,
focusing on a new species (Bacillus hor-
neckii sp. nov.) discovered on the surfaces
of the Kennedy Space Center cleanroom
facility in which the Phoenix lander was
assembled. Two strains that belong to this
novel species were isolated and subjected
to a comprehensive, polyphasic analysis
to characterize their taxonomic position.
Both phenotypic and genotypic analy-
ses clearly indicate that these isolates be-
long to the genus Bacillus, and represent
a novel species. In addition to the phylo-
genetic affiliation, structurally the spores
of this novel bacterium possess an extra-
neous layer, which might be responsible
for increased resistance to space radia-
tion conditions. The chemical character-
ization of this novel, extraneous layer of
spores will reveal the mechanisms be-
hind radiation resistance.
This work was done by Kasthuri J.
Venkateswaran, Alexander Probst, Parag A.
Vaishampayan, and Sudeshna Ghosh of
Caltech; and Shariff Osman of Lawrence
Berkeley National Laboratory for NASA’s Jet
Propulsion Laboratory. For more informa-
tion, contact iaoffice@jpl.nasa.gov. NPO-
46337
To better exploit the principles of gas
transport and mass transport during
the processes of cell seeding of 3D scaf-
folds and in vitro culture of 3D tissue
engineered constructs, the oscillatory
cell culture bioreactor provides a flow
of cell suspensions and culture media
directly through a porous 3D scaffold
(during cell seeding) and a 3D con-
struct (during subsequent cultivation)
within a highly gas-permeable closed-
loop tube. This design is simple, modu-
lar, and flexible, and its component
parts are easy to assemble and operate,
and are inexpensive. Chamber volume
can be very low, but can be easily scaled
up. This innovation is well suited to
work with different biological speci-
mens, particularly with cells having
high oxygen requirements and/or
shear sensitivity, and different scaffold
structures and dimensions.
The closed-loop changer is highly gas
permeable to allow efficient gas ex-
change during the cell seeding/cultur-
ing process. A porous scaffold, which
may be seeded with cells, is fixed by
means of a scaffold holder to the cham-
ber wall with scaffold/construct orienta-
tion with respect to the chamber deter-
mined by the geometry of the scaffold
holder. A fluid, with/without biological
specimens, is added to the chamber such
that all, or most, of the air is displaced
(i.e., with or without an enclosed air bub-
ble). Motion is applied to the chamber
within a controlled environment (e.g.,
oscillatory motion within a humidified
37 ºC incubator). Movement of the
chamber induces relative motion of the
scaffold/construct with respect to the
fluid. In case the fluid is a cell suspen-
sion, cells will come into contact with the
scaffold and eventually adhere to it. Al-
ternatively, cells can be seeded on scaf-
folds by gel entrapment prior to bioreac-
tor cultivation.
Subsequently, the oscillatory cell cul-
ture bioreactor will provide efficient gas
exchange (i.e., of oxygen and carbon
dioxide, as required for viability of meta-
bolically active cells) and controlled lev-
els of fluid dynamic shear (i.e., as re-
quired for viability of shear-sensitive
cells) to the developing engineered tis-
sue construct.
This bioreactor was recently utilized
to show independent and interactive ef-
fects of a growth factor (IGF-I) and slow
bidirectional perfusion on the survival,
differentiation, and contractile perform-
ance of 3D tissue engineering cardiac
constructs. 
The main application of this system
is within the tissue engineering indus-
try. The ideal final application is within
the automated mass production of tis-
sue-engineered constructs. Target in-
dustries could be both life sciences
companies as well as bioreactor device
producing companies. 
This work was done by Lisa E. Freed,
Mingyu Cheng, and Matteo G. Moretti of
Massachusetts Institute of Technology for
Johnson Space Center. For further informa-
tion, contact the Johnson Technology Transfer
Office at (281) 483-3809. 
In accordance with Public Law 96-
517, the contractor has elected to retain
title to this invention. Inquiries concern-
ing rights for its commercial use should be
addressed to:
Patent Compliance Administrator
Massachusetts Institute of Technology
Five Cambridge Center, Kendall Square
Room NE25-230
Cambridge, MA 021142-1493
Refer to MSC-24270-1, volume and num-
ber of this Medical Design Briefs issue, and
the page number.
Oscillating Cell Culture Bioreactor
This bioreactor is well suited to work with different biological specimens.
Lyndon B. Johnson Space Center, Houston, Texas
https://ntrs.nasa.gov/search.jsp?R=20100009653 2019-08-30T09:04:50+00:00Z
